This multi-institutional study evaluated the relative long-term costs of
surgical vs. medical management of severe GERD. Methods: The costs estimates
were derived from a standard discounted cash flow model. Costs represent
estimates of direct and indirect costs and professional fees. Data from the
medical records of 343 patients undergoing laparoscopic Nissen fundoplication
(LNF) by 12 surgeons were analyzed for determination of procedure related costs.
All patients had severe GERD. For determination of medical costs prior to
surgery, the office records of 144 of the 343 patients treated by 8
gastroenterologists were analyzed.
Results:
Cost of Medical Management (N=144)
Cost component Mean Yearly Cost(0 Projected 10 year
Discounted Cost (0
Medication* 1,352 10,440
Office Visits 115 888
Medical Tests 196 1,955
Lost Work Time 525 4,053
Total ,188 ,336
*84% of patients were on maintenance Omeprazole therapy
Cost of Surgical Management (N=344)
Cost component Mean perioperative Projected 10 year
Cost (0 Discounted Cost(0
Preop. Tests 1,196 1,196
Operation costs# 11,873 11,873
Postop. costs 718 2,050
Lost work Time 750 750
Total ,233 ,869
#includes professional fees, includes cost of surgical failures
Conclusion: Medication and direct operating costs were the dominating cost
components for each mode of therapy. This study suggests that LNF compared to
medical therapy results in a costs savings over a 10 year period. The cost
of medical and surgical management for patients with severe GERD is equal at
approximately 8 years, beyond which medical therapy exceeds the cost of LNF.